CG Oncology, Inc. - CGON

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$6.399B
QoQ value delta ($000)
+$2.884B (+82.06%)
Implied price effect (QoQ)
+57.89%
Shares
Total shares
97,628,754
QoQ shares delta
+12,963,378 (+15.31%)
Total shares held by funds (by quarter)

Market chart (CGON)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 237 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
RTW INVESTMENTS, LP 472,731 6,984,808 4.7%
T. Rowe Price Investment Management, Inc. 454,836 6,720,389 0.31%
Decheng Capital LLC 431,234 6,371,669 65.21%
WELLINGTON MANAGEMENT GROUP LLP 363,524 5,371,232 0.07%
BlackRock, Inc. 342,743 5,064,180 0.01%
VANGUARD GROUP INC 271,519 6,539,482 0.0%
FMR LLC 254,804 3,764,844 0.01%
TCG Crossover Management, LLC 248,399 3,670,206 7.11%
PRICE T ROWE ASSOCIATES INC /MD/ 247,234 3,652,980 0.03%
VANGUARD PORTFOLIO MANAGEMENT LLC 209,476 3,095,098 0.01%
VANGUARD CAPITAL MANAGEMENT LLC 205,315 3,033,625 0.01%
Caption Management, LLC 186,720 2,758,880 1.09%
STATE STREET CORP 179,152 2,647,054 0.01%
Foresite Capital Management VI LLC 150,349 2,221,474 32.67%
GEODE CAPITAL MANAGEMENT, LLC 108,101 1,596,864 0.01%
FRANKLIN RESOURCES INC 101,994 1,507,005 0.02%
BANK OF AMERICA CORP /DE/ 98,092 1,449,364 0.01%
DV Trading LLC 97,418 1,439,393 2.31%
UBS Group AG 88,794 1,311,978 0.01%
GOLDMAN SACHS GROUP INC 78,457 1,159,239 0.01%
ACORN CAPITAL ADVISORS, LLC 76,579 1,130,501 21.77%
EcoR1 Capital, LLC 74,583 1,102,000 3.17%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 72,076 1,064,966 0.01%
Foresite Capital Management V, LLC 67,954 1,004,050 25.08%
DRIEHAUS CAPITAL MANAGEMENT LLC 67,654 999,623 0.5%